https://clinicaltrials.gov/ct2/show/NCT04206007?type=Intr&cond=COPD&sfpd_d=14&sel_rss=new14 Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease The Safety and Feasibility of UMC119-06 Cell Therapy in Subjects With Chronic Obstructive Pulmonary Disease Condition : Chronic Obstructive Pulmonary Disease Moderate Intervention : Biological: UMC119-06 Sponsor : Meridigen Biotech Co., Ltd. Not yet recruiting NCT04206007 Fri, 20 Dec 2019 12:00:00 EST
